Search for: "J. A. C."
Results 9021 - 9040
of 19,466
Sorted by Relevance
|
Sort by Date
12 Nov 2008, 3:50 pm
This constitutes a waiver under P-C R. 1(1)(8), set forth above [read post]
7 Mar 2018, 10:34 am
(Check for commentary on CanLII Connects) The most-consulted French-language decision was Mugesera c. [read post]
2 Jul 2024, 6:42 am
J. [read post]
18 Jan 2012, 9:33 am
J. [read post]
8 Apr 2020, 12:44 pm
c=lnj. [read post]
19 Jun 2007, 7:31 am
Hickey and Roger C. [read post]
13 Jun 2012, 4:01 pm
C-4363—appears here on the FTC website. [read post]
29 Jun 2017, 9:29 am
On this latter point, Gascon J. presumed expertise as the parties chose the arbitrator to adjudicate that very dispute. [read post]
12 Mar 2010, 9:40 am
(privacy law and the Internet) CWRU Law Stacks KF390.5.C6 G573 2009 Margaret C. [read post]
7 Mar 2011, 12:40 am
Mann J’s enforcement of the US copyright was therefore reversed. [read post]
8 Apr 2020, 12:44 pm
c=lnj. [read post]
3 May 2021, 9:40 am
C. [read post]
6 Jul 2010, 11:03 am
Circuit (Judges Henderson, Griffith, and Williams) ruled in a 2-1 decision (Judge Henderson dissenting) also concerning Teva’s ANDAs for losartan drug products, that the patent delisting counterclaim provision at FDC Act § 505(j)(5)(C)(ii)(I) added by the 2003 Medicare Modernization Act must be read together with the patent delisting forfeiture provision at FDC Act § 505(j)(5)(D)(i)(I)(bb)(CC), and that there is “no reason to conclude that the 2003… [read post]
15 Jun 2007, 11:07 am
State of Indiana (NFP) John J. [read post]
3 Sep 2008, 1:27 am
So, for example, Section 194-C applies to any person responsible for paying any "sum" to any resident for carrying out any work, and Section 195 to a person responsible for paying a non-resident any "interest or any other sum chargeable under the provisions of this Act". [read post]
6 Nov 2009, 12:35 am
Morgenthau, District Attorney, New York (Timothy C. [read post]
2 May 2008, 1:09 am
May 01, 2008) (NO. 3534, 3994/05)Steven Banks, The Legal Aid Society, New York (Michael C. [read post]
2 Jun 2022, 3:00 am
Since 1984, generic drugs have been approved under ANDAs pursuant to section 505(j) of the Federal Food, Drug, and Cosmetic Act (FDCA); before 1984, no formal mechanism for an ANDA existed so FDA used sections 505(b) and 505(c) to approve follow-on drugs based on the Agency’s previous findings of safety and efficacy. [read post]
4 Apr 2020, 11:48 am
Heath Coffman, & Kevin C. [read post]
29 May 2015, 12:53 pm
Rev. 559 (2005) (15,610 downloads) Jay C. [read post]
